OTCMKTS:CRLBF

Cresco Labs (CRLBF) Stock Price, News & Analysis

Cresco Labs logo
$0.45 -0.02 (-4.64%)
As of 03:59 PM Eastern

About Cresco Labs Stock (OTCMKTS:CRLBF)

Advanced

Key Stats

Today's Range
$0.45
▼
$0.50
50-Day Range
$0.45
▼
$0.79
52-Week Range
$0.45
▼
$2.30
Volume
848,569 shs
Average Volume
702,001 shs
Market Capitalization
$167.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Cresco Labs is a U.S. cannabis company founded in Chicago in 2013. It cultivates and processes cannabis, manufactures branded products, and sells through wholesale channels and its own retail stores in licensed markets.

The company’s product portfolio includes cannabis flower, vapes, concentrates, edibles and other cannabis products. Its brands include Cresco, High Supply, FloraCal and Good News, and it operates retail dispensaries under the Sunnyside name.

Cresco Labs serves both medical and adult-use cannabis customers, with operations spanning multiple U.S. states. Its activities are subject to state-specific cannabis laws and regulations.

AI Generated. May Contain Errors.

Cresco Labs Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

CRLBF MarketRank™: 
1.16132101114 of 5 stars

Cresco Labs scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cresco Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Cresco Labs has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cresco Labs' stock forecast and price target.
  • Earnings Growth

    Earnings for Cresco Labs are expected to remain at ($0.07) per share in the coming year.

  • Price to Book Value per Share Ratio

    Cresco Labs has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.29% of the float of Cresco Labs has been sold short.
  • Short Interest Ratio / Days to Cover

    Cresco Labs has a short interest ratio ("days to cover") of 1.38, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cresco Labs has recently decreased by 21.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cresco Labs does not currently pay a dividend.

  • Dividend Growth

    Cresco Labs does not have a long track record of dividend growth.

  • Search Interest

    Only 3 people have searched for CRLBF on MarketBeat in the last 30 days. This is a decrease of -85% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cresco Labs insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    0.05% of the stock of Cresco Labs is held by institutions.

  • Read more about Cresco Labs' insider trading history.
Receive CRLBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRLBF Stock News Headlines

Cresco Labs Inc. (CRLBF) Q3 2026 Earnings Call Transcript
Cresco Labs Q1 Net Loss Narrows
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel
Cresco Labs Reports Third Quarter 2026 Financial Results
See More Headlines

CRLBF Stock Analysis - Frequently Asked Questions

Cresco Labs' stock was trading at $1.23 at the beginning of the year. Since then, CRLBF stock has decreased by 63.4% and is now trading at $0.4501.

Cresco Labs Inc. (OTCMKTS:CRLBF) posted its quarterly earnings results on Friday, November, 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The firm earned $172.78 million during the quarter, compared to analyst estimates of $173.66 million. Cresco Labs had a negative net margin of 14.61% and a negative trailing twelve-month return on equity of 6.36%.

Shares of CRLBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cresco Labs investors own include Curaleaf (CURLF), Trulieve Cannabis (TCNNF), Green Thumb Industries (GTBIF), Canopy Growth (CGC), Tilray Brands (TLRY), NVIDIA (NVDA) and Aurora Cannabis (ACB).

Company Calendar

Last Earnings
11/06/2026
Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CRLBF
CIK
1832928
Fax
N/A
Employees
2,900
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($0.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$135.41 million
Net Margins
-14.61%
Pretax Margin
-14.93%
Return on Equity
-6.36%
Return on Assets
-1.31%

Debt

Debt-to-Equity Ratio
1.86
Current Ratio
2.27
Quick Ratio
1.28

Sales & Book Value

Annual Sales
$655.85 million
Price / Sales
0.26
Cash Flow
$0.04 per share
Price / Cash Flow
12.26
Book Value
$0.68 per share
Price / Book
0.66

Miscellaneous

Outstanding Shares
372,350,000
Free Float
N/A
Market Cap
$167.59 million
Optionable
Not Optionable
Beta
1.60

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:CRLBF) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners